Clene Inc. (CLNN) Dividend History

Company News

• Clene to Present at the H.C. Wainwright 26th Annual Global Investment Conference

  Clene Inc., a clinical-stage biopharmaceutical company, announced that it will present at the H.C. Wainwright 26th Annual Global Investment Conference and host 1x1 investor meetings on September 9, 2024.

  GlobeNewswire Inc.
• Crude Oil Down 1%; Soligenix Shares Surge - Helen Of Troy (NASDAQ:HELE) - Benzinga

  Crude oil prices declined by 1%, while shares of Soligenix surged 282% after the company announced positive interim results for its HyBryte treatment. Helen of Troy reported soft Q1 earnings and lowered its FY25 guidance, leading to a 30% drop in its stock price.

  Benzinga

  Featured Companies: HELE QURE SNGX
• Clene Inc. (CLNN) Reports Q1 Loss, Lags Revenue Estimates

  Clene (CLNN) delivered earnings and revenue surprises of 0% and 54.38%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

  Zacks Investment Research

  Featured Companies: FOLD
• 10 Top Penny Stocks To Watch Right Now For Under $1

  Top 10 Penny Stocks To Watch Under $1 This Week. The post 10 Top Penny Stocks To Watch Right Now For Under $1 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

  PennyStocks

  Featured Companies: BNGO CMND CYBN
• Why Shares of Clene Jumped 11.8% on Monday

  The company's lead therapy has shown progress against ALS in preliminary trials.

  The Motley Fool